Novo Nordisk creates new RNA and gene therapy unit
Novo Nordisk is establishing a new technology area for RNA and gene therapy with the aim of investigating new treatments across the company's platform.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL PEDERSEN
Novo Nordisk is now seriously beginning to dedicate time and resources to finding new treatment options within RNA and gene therapies, informs Senior Vice President of Global Research Technologies at Novo Nordisk Lars Fogh Iversen in a statement on Linkedin.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
